U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. IMLYGIC (talimogene laherparepvec)
  1. Vaccines, Blood & Biologics

IMLYGIC (talimogene laherparepvec)

STN:  125518
Proper Name: talimogene laherparepvec
Tradename: IMLYGIC
Manufacturer: Amgen Inc.
Indication:

  • Indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with melanoma recurrent after initial surgery.

Product Information

Supporting Documents